TMER1-i (Crossignal Therapeutics)

N/A

Report date: 2025/06/11 11:06:48
NME

Base Information

Drug NameTMER1-i (Crossignal Therapeutics)
Drug Alias NameTreg modulator (Crossignal Therapeutics)
ClassificationSmall molecules
Mechanisms of ActionRegulatory T-lymphocytes inhibitorsImmunostimulantsG-protein coupled receptor 35 inhibitors
TargetsG-protein coupled receptor 35
Therapy Area/IndicationsSolid tumoursStomach NeoplasmsColonic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossignal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrossignal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursStomach NeoplasmsColonic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A